Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Atropine for the Prevention of Myopia Progression in Danish Children - a Randomized, Double-masked, Multicenter, 36-month Prospective 1:1:1 Study of Safety and Efficacy of 0.1% Atropine Loading Dose to Single 0.01% Atropine and Placebo

NCT03911271 is registered in ClinicalTrials.gov with Line Kessel as lead sponsor.

NCT NCT03911271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03911271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Atropine for the Prevention of Myopia Progression in Danish Children - a Randomized, Double-masked, Multicenter, 36-month Prospective 1:1:1 Study of Safety and Efficacy of 0.1% Atropine Loading Dose to Single 0.01% Atropine and Placebo
Lead sponsor
Line Kessel
Phase
Phase 2
Overall status
Completed
Start date
May 30, 2019
Completion date
April 23, 2024
Enrollment
97 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myopia